Christophe Pasquier

5.0k total citations
135 papers, 3.8k citations indexed

About

Christophe Pasquier is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Christophe Pasquier has authored 135 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Infectious Diseases, 57 papers in Virology and 49 papers in Epidemiology. Recurrent topics in Christophe Pasquier's work include HIV Research and Treatment (55 papers), HIV/AIDS drug development and treatment (42 papers) and HIV/AIDS Research and Interventions (38 papers). Christophe Pasquier is often cited by papers focused on HIV Research and Treatment (55 papers), HIV/AIDS drug development and treatment (42 papers) and HIV/AIDS Research and Interventions (38 papers). Christophe Pasquier collaborates with scholars based in France, Cameroon and Tunisia. Christophe Pasquier's co-authors include Jacques Izopet, Karine Sauné, Patrice Massip, J Puel, Louis Bujan, B. Marchou, Michelle Cazabat, Pierre Delobel, Martine Dubois and Karine Sandres and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Christophe Pasquier

133 papers receiving 3.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Christophe Pasquier 1.8k 1.7k 1.5k 1.1k 380 135 3.8k
Jorge del Romero 2.2k 1.2× 1.6k 1.0× 1.5k 1.0× 515 0.5× 224 0.6× 144 3.7k
Carmen de Mendoza 3.3k 1.8× 1.7k 1.0× 2.6k 1.8× 1.2k 1.0× 166 0.4× 274 5.1k
Henry Pollack 902 0.5× 1.0k 0.6× 701 0.5× 372 0.3× 197 0.5× 57 2.0k
Suzanne Jurriaans 3.7k 2.1× 1.7k 1.0× 3.5k 2.4× 815 0.7× 161 0.4× 128 5.6k
Patrice Massip 2.5k 1.4× 1.0k 0.6× 2.3k 1.5× 161 0.1× 230 0.6× 127 4.0k
Annemarie Berger 1.7k 1.0× 1.8k 1.1× 736 0.5× 995 0.9× 129 0.3× 130 3.7k
Heiko Jessen 1.5k 0.9× 2.6k 1.6× 1.7k 1.2× 323 0.3× 139 0.4× 71 4.8k
Janet M. McNicholl 2.7k 1.5× 2.0k 1.2× 1.6k 1.1× 154 0.1× 259 0.7× 118 4.0k
James W. Bremer 1.3k 0.7× 823 0.5× 1.2k 0.8× 128 0.1× 99 0.3× 71 2.5k
J Pillot 738 0.4× 1.2k 0.7× 443 0.3× 976 0.9× 129 0.3× 129 2.6k

Countries citing papers authored by Christophe Pasquier

Since Specialization
Citations

This map shows the geographic impact of Christophe Pasquier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Pasquier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Pasquier more than expected).

Fields of papers citing papers by Christophe Pasquier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Pasquier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Pasquier. The network helps show where Christophe Pasquier may publish in the future.

Co-authorship network of co-authors of Christophe Pasquier

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Pasquier. A scholar is included among the top collaborators of Christophe Pasquier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Pasquier. Christophe Pasquier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Migueres, Marion, Sabine Chapuy‐Regaud, Christophe Pasquier, Jacques Izopet, & Jean‐Michel Mansuy. (2025). Outbreak of parvovirus B19 disease in France: urgent need in public health for relevant tools to track epidemics in real-time. BMJ Global Health. 10(4). e016658–e016658. 1 indexed citations
3.
Pasquier, Christophe, et al.. (2024). HPV genotyping in clinical samples using long‐read single‐molecule real‐time sequencing. Journal of Medical Virology. 96(5). e29652–e29652. 2 indexed citations
4.
5.
Izopet, Jacques, et al.. (2022). A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome. International Journal of Infectious Diseases. 125. 135–137. 19 indexed citations
6.
Pasquier, Christophe, et al.. (2016). Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus. Diagnostic Microbiology and Infectious Disease. 87(1). 25–27. 8 indexed citations
7.
Njouom, Richard, et al.. (2008). Efficacy and safety of peginterferon alpha‐2a/ribavirin in treatment‐naive Cameroonian patients with chronic hepatitis C. Journal of Medical Virology. 80(12). 2079–2085. 9 indexed citations
8.
9.
Pasquier, Christophe, et al.. (2006). Implication of neutral polysaccharides associated to alginate in inhibition of murine macrophage response to Pseudomonas aeruginosa. FEMS Microbiology Letters. 147(2). 195–202. 2 indexed citations
10.
Puissant‐Lubrano, Bénédicte, F. Roubinet, Patrice Massip, et al.. (2006). Analysis of CCR5, CCR2, CX 3 CR1, and SDF1 Polymorphisms in HIV-Positive Treated Patients: Impact on Response to HAART and on Peripheral T Lymphocyte Counts. AIDS Research and Human Retroviruses. 22(2). 153–162. 25 indexed citations
11.
Delobel, Pierre, Karine Sauné, Michelle Cazabat, et al.. (2005). R5 to X4 Switch of the Predominant HIV-1 Population in Cellular Reservoirs During Effective Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(4). 382–392. 94 indexed citations
12.
Pasquier, Christophe, et al.. (2002). Virus et sperme : implications en assistance médicale à la procréation. Virologie. 6(2). 105–111. 3 indexed citations
13.
Izopet, Jacques, Christophe Pasquier, Karine Sauné, et al.. (2002). Evolution of Total and Integrated HIV-1 DNA and Change in DNA Sequences in Patients with Sustained Plasma Virus Suppression. Virology. 302(2). 393–404. 26 indexed citations
14.
Bujan, Louis, Myriam Daudin, Muriel Alvarez, et al.. (2002). Intermittent human immunodeficiency type 1 virus (HIV-1) shedding in semen and efficiency of sperm processing despite high seminal HIV-1 RNA levels. Fertility and Sterility. 78(6). 1321–1323. 25 indexed citations
15.
Izopet, Jacques, Karine Sauné, G. Salama, et al.. (2001). Infections nosocomiales à VHC en hémodialyse. Annales de biologie clinique. 59(5). 7–8. 3 indexed citations
16.
Pasquier, Christophe, Richard Njouom, Karine Sandres, et al.. (2001). HIV-1 subtyping using phylogenetic analysis of pol gene sequences. Journal of Virological Methods. 94(1-2). 45–54. 81 indexed citations
17.
Izopet, Jacques, Christophe Pasquier, Karine Sandres, J Puel, & Lionel Rostaing. (1999). Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. Journal of Medical Virology. 58(2). 139–144. 74 indexed citations
18.
Kobrin, Isaac, et al.. (1991). The Effect of Cilazapril, a New Angiotensin Converting Enzyme Inhibitor, on Peak and Trough Blood Pressure Measurements in Hypertensive Patients. Journal of Cardiovascular Pharmacology. 17(1). 8–12. 9 indexed citations
19.
Steg, Philippe Gabríel, Christophe Pasquier, Thuy Pham, et al.. (1990). Evidence foe neutrophil and complement activation early after PTCA. Journal of the American College of Cardiology. 15(2). A164–A164. 4 indexed citations
20.
Pasquier, Christophe, et al.. (1976). [Origin of urinary hyperexcretion of cAMP in the irradiated animal. Use of a viral lymphocyte depletion technic].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 34(4). 255–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jorge del Romero Breakdown of academic impact, for papers by Carmen de Mendoza Breakdown of academic impact, for papers by Henry Pollack Breakdown of academic impact, for papers by Suzanne Jurriaans Breakdown of academic impact, for papers by Patrice Massip Breakdown of academic impact, for papers by Annemarie Berger Breakdown of academic impact, for papers by Heiko Jessen Breakdown of academic impact, for papers by Janet M. McNicholl Breakdown of academic impact, for papers by James W. Bremer Breakdown of academic impact, for papers by J Pillot
Rankless by CCL
2026